Downs Christopher 4
4 · CNS Pharmaceuticals, Inc. · Filed Dec 7, 2021
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-12-06$0.94/sh+5,000$4,702→ 151,500 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.9400 to $0.947299. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.